1. Invasive disease-free survival was significantly higher in patients receiving adjuvant ribociclib + NSAI when compared to patients receiving NSAI ...
1. There were similar rates of ipsilateral invasive recurrence among the postoperative adjuvant radiotherapy group (group 1) and non-radiotherapy group ...
Click to read this study in The Lancet Oncology.
Click to read this study in Journal of Clinical Oncology.
Click to read this study in JAMA Oncology.
Click to read this study in JAMA Network Open.
Click to read the study in The Lancet Oncology.
Click to read the study in Clinical Cancer Research.
Click to read the study in the Journal of Clinical Oncology.
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
